Brief: Hamlet Pharma Q4 Loss Before Tax Narrows To SEK 6.5 Mln
28/08/2020 07:40
Aug 28 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* Q4 YEAR-END REPORT JULY 2019 - JUNE 2020
* Q4 LOSS BEFORE TAX AMOUNTED TO KSEK -6,471 (-6,665)
* Q4 OTHER OPERATING INCOME TOTALED KSEK 448 (0)
Source text for Eikon: ID:nWkrbj0TyV
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe